There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > ILDR2


ILDR2 Molecule Information

Name:Immunoglobulin-like domain-containing receptor 2
Target Synonym:Immunoglobulin-like domain-containing receptor 2?ILDR2?C1orf32?Immunoglobulin-Like Domain Containing Receptor 2?LISCH-Like?DJ782G3.1?Immunoglobulin Like Domain Containing Receptor 2?Chromosome 1 Open Reading Frame 32
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:1
Lastest Research Phase:Phase 1 Clinical

ILDR2 Protein Product ListCompare or Buy

By Product Status:
By Product Category:
By Species:
By Conjugate:
Cat. No. Species Product Description Structure Purity Feature
IL2-H5259 Human Human ILDR2 Protein, Fc Tag
IL2-H52H7 Human Human ILDR2 Protein, His Tag
IL2-M52H5 Mouse Mouse ILDR2 Protein, His Tag

ILDR2 Molecule Synonym Name


ILDR2 Molecule Background

ILDR2 belongs to the immunoglobulin superfamily. May be involved in lipid homeostasis and ER stress pathways. ILDR2 as a novel B7-like protein with robust T cell inhibitory activity, expressed in immune cells and in immune-privileged and inflamed tissues. A fusion protein, consisting of ILDR2 extracellular domain with an Fc fragment, that binds to a putative counterpart on activated T cells showed a beneficial effect in the collagen-induced arthritis model and abrogated the production of proinflammatory cytokines and chemokines in autologous synovial-like cocultures of macrophages and cytokine-stimulated T cells. Collectively, these findings point to ILDR2 as a novel negative regulator for T cells, with potential roles in the development of immune-related diseases, including autoimmunity and cancer.

ILDR2 References

ILDR2 Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
BAY-1905254 BAY-1905254 Phase 1 Clinical Compugen Neoplasms Details

This web search service is supported by Google Inc.